Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a strong player in the global household and personal care industry, with a dominant position in the oral care market. While they have faced challenges in the US and pet food sectors, their international business remains a key factor for success. The company should focus on targeting the premium oral care market and integrating sustainability into their strategy to continue their growth trajectory.

Bears say

Colgate-Palmolive is facing several challenges that have negatively impacted its performance, including self-inflicted wounds, increased competition, and an innovation gap. These issues have led to market share pressure and slowed category growth. Additionally, the company's focus on line extensions rather than core innovation has contributed to its underperformance. Colgate-Palmolive must address these issues and implement meaningful innovation to regain market share and drive growth. However, the company has a strong board and management diversity, and its cost-saving initiatives and potential growth in emerging markets may provide future upside.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.